Team:Tsinghua

From 2014.igem.org

(Difference between revisions)
Line 33: Line 33:
</div>
</div>
<div id="text2">
<div id="text2">
-
<h1 style="font-size: 22px;"><font color="990099">T1DM</font> results from the autoimmune destruction of insulin-producing beta cells in the pancreas. We aim to convert somatic cells into insulin-producing cells regulated by blood glucose, and eliminate the need for constant insulin therapy.</h1>  
+
<h1><font color="990099">T1DM</font> results from the autoimmune destruction of insulin-producing beta cells in the pancreas. We aim to convert somatic cells into insulin-producing cells regulated by blood glucose, and eliminate the need for constant insulin therapy.</h1>  
</div>
</div>
</span>
</span>

Revision as of 20:59, 14 October 2014

Tsinghua 2014

Hi, we are Team Tsinghua at iGEM 2014. We are working on a gene therapy for Type 1 Diabetes Mellitus (T1DM).

Scroll down

T1DM results from the autoimmune destruction of insulin-producing beta cells in the pancreas. We aim to convert somatic cells into insulin-producing cells regulated by blood glucose, and eliminate the need for constant insulin therapy.

Scroll down

We use Adeno-associated viral (AAV) vectors to introduce genes, which has proven to be safe… Well, that’s a whole other story, want to know more?

Scroll down